In terms of market performance, Adaptive Biotechnologies Corp had a fairly uneven. The highest value for the stock in the past year was $5.80 on 10/07/24, and the lowest value was recorded at $2.28 on 04/19/24.
52-week price history of ADPT Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Adaptive Biotechnologies Corp’s current trading price is -22.00% away from its 52-week high, while its distance from the 52-week low is 98.25%. The stock’s price range during the 52-week period has remained between $2.28 and $5.80. In the Healthcare sector, the company’s shares saw a trading volume of around 0.66 million for the day, which was evidently lower than the average daily volume of 1.16 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Adaptive Biotechnologies Corp (ADPT) has experienced a quarterly rise of 0.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 666.56M and boasts a workforce of 709 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.29, with a change in price of +1.21. Similarly, Adaptive Biotechnologies Corp recorded 1,247,307 in trading volume during the last 100 days, posting a change of +36.56%.
Examining ADPT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ADPT stands at 0.94. Similarly, the long-term debt-to-equity ratio is also 0.90.
ADPT Stock Stochastic Average
As of today, Adaptive Biotechnologies Corp’s raw stochastic average for the last 50 days stands at 29.71%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 5.56%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 27.62% and 33.45%, respectively.
ADPT Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -7.76%.However, over the last six months, we can see a weaker performance of 73.18%. Over the last 30 days, the price of ADPT has fallen by 13.00%. And in the last five days, it has fallen by -2.59%.
